KDventures CSO John Öhd transitions to senior advisor role

• KDventures announced today that John Öhd is transitioning from chief scientific officer to senior advisor.
• Öhd will focus his operational efforts on portfolio company Modus Therapeutics.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. KDventures AB published the original content used to generate this news brief on October 15, 2026, and is solely responsible for the information contained therein.